Skip to content
Balance Sheet · TASI 8070

Arabian Shield Cooperative Insurance Co.
Cash and cash equivalents history.

Cash and near-cash balances reported at the reporting date. Explore 15 reported observations from 2022 to 2026, with every value linked to its official evidence.

Coverage2022–202615 source-linked periods
Annual history4annual reporting periods
Interim history11quarterly or year-to-date periods
StatementBalance Sheetas reported by the issuer
Annual series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2025IFRS 17Cash and cash equivalents259.17M SAR

Reporting basis changed · 2023

Cash and cash equivalents0100M200M300M2022202320242025
Hover or tap to exploreSAR
First-quarter series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2026HISTORICALCash and cash equivalents536.92M SAR
Cash and cash equivalents0200M400M600M202420252026
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2026IFRS 17Cash and cash equivalents801.32M SAR
Cash and cash equivalents0200M400M600M800M1B2023202420252026
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2026IFRS 17Cash and cash equivalents785.85M SAR
Cash and cash equivalents0200M400M600M800M2023202420252026
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
9M / Q3 20262026-09-30785,84830 September 2026785.85M SARCash and cash equivalentsNote 9Official p. 5 ↗Open statement →
H1 / Q2 20262026-06-30801,3152026-06-30 (Unaudited)801.32M SARCash and cash equivalentsOfficial p. 5 ↗Open statement →
Q1 20262026-03-31536,92031 March 2026 (Unaudited)536.92M SARCash and cash equivalentsNote 9Signed copy p. 5 ↗Saudi Exchange filing ↗Open statement →
FY 20252025-12-31259,1682025-12-31259.17M SARCash and cash equivalentsNote 9Official p. 150 ↗Open statement →
9M / Q3 20252025-09-30300,30530 September 2025 · SAR’000300.31M SARCash and cash equivalentsOfficial p. 5 ↗Open statement →
H1 / Q2 20252025-06-30190,87430 June 2025 · SAR’000190.87M SARCash and cash equivalentsOfficial p. 5 ↗Open statement →
Q1 20252025-03-31167,14331 March 2025 · SAR’000167.14M SARCash and cash equivalentsOfficial p. 5 ↗Open statement →
FY 20242024-12-3182,0182024-12-3182.02M SARCash and cash equivalentsNote 9Official p. 15 ↗Open statement →
9M / Q3 20242024-09-3049,97930 September 2024 · SAR’00049.98M SARCash and cash equivalentsOfficial p. 5 ↗Open statement →
H1 / Q2 20242024-06-30138,97930 June 2024 · SAR’000138.98M SARCash and cash equivalentsNote 9Official p. 5 ↗Open statement →
Q1 20242024-03-31124,62631 March 2024 · SAR’000124.63M SARCash and cash equivalentsOfficial p. 5 ↗Open statement →
FY 20232023-12-31Restated comparative figures in an audited report160,9712023-12-31 (Restated & audited)160.97M SARCash and cash equivalentsNote 9Official p. 15 ↗Open statement →
9M / Q3 20232023-09-302468222023-09-30246.82M SARCash and cash equivalentsOfficial p. 5 ↗Open statement →
H1 / Q2 20232023-06-301294872023-06-30129.49M SARCash and cash equivalentsOfficial p. 5 ↗Open statement →
FY 20222022-12-31146,0942022-12-31146.09M SARCash and cash equivalentsNote 7Official p. 11 ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

الدرع العربي — Cash and cash equivalents

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.